SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-007857
Filing Date
2024-05-13
Accepted
2024-05-13 06:16:36
Documents
5
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 6-K aciu-20240513x6k.htm 6-K 25761
2 EX-99.1 aciu-20240513xex99d1.htm EX-99.1 551088
3 EX-99.2 aciu-20240513xex99d2.htm EX-99.2 167167
4 EX-99.3 aciu-20240513xex99d3.htm EX-99.3 162889
5 GRAPHIC aciu-20240513xex99d3001.jpg GRAPHIC 3076
  Complete submission text file 0001558370-24-007857.txt   912356
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 24936766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)